Lipoprotein(a) Foundation Hosts Gala Fundraiser to Celebrate Opening of Lipoprotein Exhibition at the International Museum of Surgical Science

The Lipoprotein(a) Foundation:

WHAT:

     

The Lipoprotein(a) Foundation is hosting a Gala Fundraiser to celebrate the opening of the Understanding Lipoproteins: Research, Treatment and Relationship to Cholesterol exhibition at the International Museum of Surgical Science (IMSS)

ˆ All proceeds from the Hope Gala go to support the REVEAL Lipoprotein(a) Patient Natural History Registry to further Lp(a) research

WANT TO BUILD A FINANCIAL EMPIRE?

Subscribe to the Global Banking & Finance Review Newsletter for FREE
Get Access to Exclusive Reports to Save Time & Money

By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

ˆ Sponsored by Amgen, Inc., Akcea Therapeutics, Denka Seiken, Arrowhead Pharmaceuticals, Kaneka Corporation and IONIS Pharmaceuticals

ˆ The Hope Gala will showcase the Understanding Lipoproteins Exhibition, which is dedicated to pioneering University of Chicago researcher, Angelo M. Scanu, M.D.

ˆ Hope Gala Press Release

 

WHEN:

The Hope Gala: Lp(a) Research From the Bench to the Clinic: Reflections on the Past, the Present and the Future takes place on Saturday, November 10 at 7pm

ˆ The Understanding Lipoproteins exhibit opens to the public on Monday, November 12

ˆ Hope Gala Registration

 

WHERE:

International Museum of Surgical Science (IMSS)

1524. N. Lake Shore Drive, Chicago, IL

 

WHY:

The Understanding Lipoproteins exhibit reviews the health impact of lipoproteins, particles in the blood that carry what is often referred to as bad and good cholesterol

ˆ It is estimated that 63 million in the US have inherited high Lp(a)

ˆ Lp(a) concentrations can be measured by a simple blood test, but it is not included in most standard lipid panel tests that check cholesterol levels

ˆ A study published in JACC shows that the current cholesterol screening will miss 8% of people who have a cardiovascular event whose only risk factor is high Lp(a)

 

WHO:

The following cardiovascular event survivors and cardiovascular disease experts are available to discuss hereditary risks of cardiovascular disease associated with Lp(a):

ˆ Sandra Revill Tremulis, survivor and founder of Lipoprotein(a) Foundation

ˆ Celina Edelstein, University of Chicago research scientist and Dr Scanus colleague

ˆ Henry Ginsberg, MD Columbia College of Physicians and Surgeons and Chief Medical Officer for The Lipoprotein(a) Foundation

ˆ Monica Stokes, International Museum of Surgical Science

The Lipoprotein(a) Foundation
Chris K. Joseph, 510-435-4031
[email protected]